GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 172 filers reported holding GW PHARMACEUTICALS PLC in Q2 2017. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $35,000 | -25.5% | 307 | -36.8% | 0.00% | -50.0% |
| Q3 2020 | $47,000 | -78.4% | 486 | -80.5% | 0.00% | -85.7% |
| Q1 2020 | $218,000 | +7.4% | 2,489 | +28.3% | 0.01% | +27.3% |
| Q4 2019 | $203,000 | +88.0% | 1,940 | +209.9% | 0.01% | +57.1% |
| Q3 2019 | $108,000 | 0.0% | 626 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $108,000 | +45.9% | 626 | +42.3% | 0.01% | +40.0% |
| Q1 2019 | $74,000 | +48.0% | 440 | -13.9% | 0.01% | +25.0% |
| Q4 2018 | $50,000 | -30.6% | 511 | +23.1% | 0.00% | -20.0% |
| Q3 2018 | $72,000 | +67.4% | 415 | +37.9% | 0.01% | +66.7% |
| Q2 2018 | $43,000 | +38.7% | 301 | +8.3% | 0.00% | +50.0% |
| Q1 2018 | $31,000 | -16.2% | 278 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $37,000 | +117.6% | 278 | +70.6% | 0.00% | +50.0% |
| Q3 2017 | $17,000 | +6.2% | 163 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $16,000 | -20.0% | 163 | 0.0% | 0.00% | -33.3% |
| Q1 2017 | $20,000 | -80.8% | 163 | -79.3% | 0.00% | -85.0% |
| Q3 2016 | $104,000 | +1633.3% | 786 | +1109.2% | 0.02% | +1900.0% |
| Q2 2016 | $6,000 | -40.0% | 65 | -52.9% | 0.00% | -66.7% |
| Q1 2016 | $10,000 | +42.9% | 138 | +38.0% | 0.00% | +50.0% |
| Q4 2015 | $7,000 | -22.2% | 100 | 0.0% | 0.00% | -33.3% |
| Q3 2015 | $9,000 | -25.0% | 100 | 0.0% | 0.00% | -25.0% |
| Q2 2015 | $12,000 | +33.3% | 100 | 0.0% | 0.00% | +100.0% |
| Q1 2015 | $9,000 | +12.5% | 100 | 0.0% | 0.00% | -33.3% |
| Q4 2014 | $8,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|